medigraphic.com
Boletín Médico del Hospital Infantil de México

2007, Number 2

<< Back Next >>

Bol Med Hosp Infant Mex 2007; 64 (2)

Moyamoya disease

Urrutia-Ruiz M, Barragán-Pérez E, Hernández-Aguilar J, Garza-Morales S, Cruz-Martínez E, Santana-García F, Escobar-Mendoza E

Language: Spanish
References: 27
Page: 99-106
PDF size: 164.00 Kb.


ABSTRACT

Introduction. Objective: Describe the evolution of moyamoya disease in children attended in the Hospital Infantil de Mexico from 1995 to 2005.
Material and methods. Retrospective and descriptive study. We retrospectively reviewed the medical records of 10 children with this diagnosis; 7 with the established criteria; 3 were excluded for not counting with angiographic conventional and angioresonance for their diagnosis. Demographic and personal information, clinical manifestations, diagnostic studies, treatment and evolution were recorded and the cases analyzed using descriptive statistics.
Results. The average age was 6.5 years and 6/7 was females. The clinical manifestation in all patients was acute or subacute hemiparesis. Associated pathologies included: Down’s syndrome (4), microcephaly (3), and congenital heart disease (2). The diagnosis was confirmed with angiography (5), magnetic resonance angiography (2). A duro-arterio-synangiosis was practiced to 2 and a temporal angiosinostosis to 1, with resolution of the motor deficit without posterior deterioration. The remaining 4 patients only received symptomatic treatment, with persistence of motor deficit and seizures.
Conclusion. The diagnosis of moyamoya disease continues to be with angiography and angioresonance. When possible, surgical correction is the treatment of choice.


REFERENCES

  1. Takeuchi K, Simizu K. Hypogenesis of bilateral internal carotid arteries. No To Shinkei. 1957; 9: 37-43.

  2. Suzuki J, Takaku A. Cerebrovascular Moya-Moya disease: Disease showing abnormal net like vessel in base of brain. Arch Neurol. 1969; 20: 288-99.

  3. Keisure U, Meyer F, Mellinger J. Moya-Moya disease: The disorder and surgical treatment. Mayo Clinic Pro. 1994; 69: 749-57.

  4. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005; 36: 2148-53.

  5. Wakai K, Tamakoshi A, Likezaki K, Fukui M, Kawamura I, Aoki E, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survery. Clin Neurol Neurosurg. 1997; 99 (Supl 2): S1-5.

  6. Uchino KI, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005; 65: 956-8.

  7. Ergoven M, Deveci M, Turgut T. Moyamoya disease and Down syndrome, Indian J Pediatr. 2005; 72: 697-9.

  8. Peña-Tapia PG, Horn P, Schmiedek P. Moyamoya disease. Rev Neurol. 2006; 43: 287-94.

  9. Sakurai K, Horiuchi Y, Ikeda H. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004; 49: 278-81.

  10. Ikeda H, Sasaki T, Yoshimoto T, Fujui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24-p26. Am J Hum Genet. 1999; 64: 533-7.

  11. Fukuyama Y, Imaizumi T, Osawa M. A long-term prognosis of children with TIA type spontaneous occlusion of the circle of Willis (moyamoya disease). Japan: Annual report 1993, their research committee on spontaneous occlusion of the circle of Willis (Moyamoya disease) of the Ministry of Health and Welfare; 1993. p. 14-7.

  12. Galicchio S, Maza E, Jaimovich R, Arroyo H. Enfermedad de Moya-Moya. Arch Arg Pediatr. 1998; 96: 263-7.

  13. Kuroda S, Nanba R, Ishikawa T. Clinical manifestation of infantile moyamoya disease. No Shinkei Geka. 2003; 31: 1073-8.

  14. Erguven M, Deveci M, Turgut T. Moyamoya disease and Down syndrome. Indian J Pediatr. 2005; 72: 697-9.

  15. Im SH, Oh CW, Kwon OK, Cho BK, Chung YS, Han DH. Involuntary movement induced by cerebral ischemia: pathogenesis and surgical outcome. J Neurosurg. 2004; 100: 877-82.

  16. Hong YH, Ahn TB, Oh CW, Jeon BS. Hemichorea as an initial manifestation of moyamoya disease: reversible striatal hypoperfusion demonstrated on single photon emission computed tomography. Mov Disord. 2002; 17: 1380-3.

  17. de Veber GA. Enfermedad de Moyamoya. Cerebrovascular disease. En: Swaiman, editor. Neurología pediátrica. Principios y prácticas. Vol II. 2006, St. Louis Baltimore, New York: Mosby; 2006. Vol. 11. 1772-3.

  18. Battistella PA, Carollo C. Clinical and neuroradiological findings of moyamoya disease in Italy. Clin Neurol Neurosurg. 1997; 99 Suppl 2: S54-7.

  19. Houkin K, Nakayama N, Kuroda S. Novel magnetic resonance angiography stage grading for Moyamoya disease. Cerebrovasc Dis. 2005; 30: 347-54.

  20. Smith ER, Scott RM. Surgical management of moyamoya syndrome. Skull Base. 2005; 15: 15-26.

  21. Han DH, Kwon OK, Byun BJ. A co-operative study: Clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien). 2000; 142: 1263-74.

  22. Fung IW, Thompson D, Ganesan V. Revascularization surgery for paediatric moyamoya: a review of the literature. Child Nerv Syst. 2005; 21: 358-64.

  23. Matsushima Y, Fukai M, Tanaka K. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol. 1981; 15: 313-20.

  24. Matsushima Y, Inaba Y. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. Child Brian. 1984; 11: 155-70.

  25. Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome outcome after surgical revascularization. Pediatrics. 2005; 116: 694-701.

  26. Calderelli M, Di Rocco C, Gaglini P. Surgical treatment of moyamoya disease in pediatric age. J Neurosurg Sci. 2001; 24: 85-91.

  27. Quintana M. Experiencia de 20 años en el manejo de la enfermedad de moyamoya. Rev Chilena Neurocir. 2004; 37: 74-82.




2020     |     www.medigraphic.com